UNSPSC 51343601: Citenazone

This classification denotes an antiviral agent with the molecular formula C7H6N4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34RU0N173Q, chemically known as 2-thiophenecarbonitrile, 5-formyl-, thiosemicarbazone but generally known as citenazone, which bears US NIH Compound Identifier 3033956. European Medicines Agency schedules Citenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07488MIG.

UNSPSC 51343601 Citenazone is a Commodity code that appears in state and local procurement activity primarily for pharmaceutical supplies and medical emergency-response products rather than citenazone specifically. The recent solicitations tagged under this code show state and local governments purchasing naloxone (opioid overdose reversal medication), safe drug deactivation systems, and other pharmaceutical inventory through both direct awards and competitive bidding processes. Issuing bodies include state health departments and county governments; the Illinois Department of Public Health and Seminole County, Florida both appear in recent activity. The work involves managing inventory through consortium piggyback contracts, processing IFB notices for emergency medical supplies, and coordinating quarterly or annual deliveries to public health facilities.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Bid 26-482DPH-PREPD-B-53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under a 12-month initial term with two optional renewal years; this was a completed award, not an open solicitation. Seminole County, Florida released IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, quarterly deliveries to the Seminole County Community Health Building in Sanford, and a two-year initial term with one-year renewal option. The mismatch between the code name (citenazone) and the actual pharmaceutical products being procured suggests either tagging error or code reuse across a broader pharmaceutical-supply family in state and local systems.